Society for Basic Urologic Research 2021 Annual Meeting: Molecular Mechanisms of Urological Diseases and Treatment Resistance

泌尿基础研究学会2021年年会：泌尿系统疾病的分子机制及治疗耐药性

• 批准号: 10384214
• 负责人: Jindan Yu
• 金额: $ 0.5万
• 依托单位: NORTHWESTERN UNIVERSITY AT CHICAGO
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-11-03 至 2022-10-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10384214
• 关键词: Address; Area; Award; Basic Science; Benign; Bioinformatics; Biological Markers; Biology; CRISPR/Cas technology; Cell Lineage; Clinic; Clinical; Clinical Research; Clustered Regularly Interspaced Short Palindromic Repeats; Collaborations; Development; Disabled Persons; Disadvantaged; Disease; Disease Resistance; Emerging Technologies; Endocrine; Environment; Environmental Risk Factor; Epigenetic Process; Fostering; Funding; Genetic; Goals; Immune response; Immunotherapy; Individual; Infection; Inflammation; Intention; Interdisciplinary Communication; Knowledge; Learning; Malignant - descriptor; Medical; Medical Students; Methodology; Minority; Modeling; Molecular; National Institute of Diabetes and Digestive and Kidney Diseases; Oral; Organoids; Pathway interactions; Persons; Physicians; Postdoctoral Fellow; Prevention; Process; Regulation; Request for Applications; Request for Proposals; Research; Research Personnel; Science; Scientist; Societies; Technology; Thinking; Transgenic Organisms; Translating; Translational Research; Travel; Urologic Diseases; Urology; Woman; career; cost; diagnostic strategy; doctoral student; environmental health disparity; epigenetic regulation; ethnic minority population; health disparity; interest; meetings; novel; novel diagnostics; novel therapeutics; patient derived xenograft model; posters; pre-clinical; racial and ethnic; recruit; stem cells; symposium; targeted treatment; therapy resistant; tool; urologic

This application requests support for the Society for Basic Urologic Research (SBUR) 2021 Annual Meeting entitled, “Molecular Mechanisms of Urological Diseases and Treatment Resistance”, which will be held on November 4-7, 2021 at the JW Marriott Orlando Grande Lakes, Orlando, FL. This conference has been held annually since 1992 and provides a unique environment to learn about the most recent advances in basic, translational, and preclinical urologic research, in addition to providing a dynamic forum for discussing how these advances could be implemented for the prevention and treatment of urological diseases. Much has been learned over the last decade regarding the molecular determinants and key pathways that regulate normal and disease processes, and a wide variety of novel therapeutic and diagnostic strategies have emerged as a result. Thus, this year’s meeting will focus on a few areas that are emerging as the cutting-edge advances in urology, including: 1) Emerging Technologies and Models for Urological Research; 2) Endocrine and Genetic regulations in Urological Biology; 3) Epigenetic Regulations of Urological Development and Diseases; 4) Infection, Inflammation, and Immune Response in Urological Biology; 5) Biomarkers, Environmental Factors, and Health Disparities in Urological Diseases; 6) Urological Stem cells, Lineage Plasticity, and Treatment Resistance. The support from this application will be used to provide 24 Travel Awards and 4 Minority Scholar Awards to disadvantaged, poorly represented, trainees and junior to mid-career investigators to defray travel costs, with the intention of providing much-needed encouragement and promotion to a career in urologic research and of enhancing the diversity of conference attendees. In addition to highlighting recent advances and identifying key knowledge gaps, the primary goals of the conference are: 1) Discuss recent advances in studying the molecular mechanisms of urologic development and diseases using contemporary technologies, with emphasis on novel methodologies and tools, genetics, epigenetics, infection, inflammation and immune response, environmental factors and health disparity, and stem cells and lineage plasticity; 2) Identify critical knowledge gaps and stimulate approaches to address them; 3) Attract leading scientists from diverse fields in malignant and benign urology; 4) Promote interactions between basic, translational and clinical research scientists of diverse backgrounds and facilitate cross-disciplinary communication and collaboration; 5) Foster the active participation of women, minorities, the disabled, and early career investigators by providing them opportunities to present and discuss cutting-edge science and enhancing their integration into the field; and 6) Disseminate and facilitate novel discoveries in urologic diseases. An attendance of at least 250 is expected, and we will recruit a large variety of clinician, physician-scientist, and basic researcher attendees, with special emphasis on early-career investigators and groups typically underrepresented in urologic research. Finally, a robust plan is in place for publicizing the conference and the support, if awarded, by NCI and NIDDK.

此应用程序请求为基础泌尿系统研究学会(SBUR)2021年会提供支持 题为《泌尿系统疾病的分子机制和治疗耐药性》，将于 2021年11月4日至7日，在佛罗里达州奥兰多的JW万豪奥兰多格兰德湖酒店。这个会议已经召开了 自1992年以来每年一次，并提供了一个独特的环境来了解基础、 转化性和临床前泌尿学研究，除了提供一个动态论坛讨论如何 这些进展可用于预防和治疗泌尿系统疾病。很多事情都发生了 在过去的十年中了解到调节正常和 因此，出现了各种新的治疗和诊断策略。 因此，今年的会议将集中在几个正在成为泌尿外科前沿进展的领域， 包括：1)泌尿外科研究的新兴技术和模型；2)内分泌和遗传学 泌尿生物学规则；3)泌尿发育和疾病的表观遗传学规则；4) 泌尿生物学中的感染、炎症和免疫反应；5)生物标志物、环境因素、 和泌尿系统疾病的健康差异；6)泌尿干细胞、谱系可塑性和治疗 抵抗。此应用程序的支持将用于提供24个旅行奖和4个少数民族学者 奖励处境不利、代表性较低的受训人员和职业生涯初级至中期的调查人员，以支付旅费 成本，目的是为泌尿外科的职业生涯提供急需的鼓励和促进 研究和提高会议与会者的多样性。除了强调最近的进展之外 和确定关键的知识差距，会议的主要目标是：1)讨论最近在 利用现代技术研究泌尿系统发育和疾病的分子机制， 侧重于新的方法和工具、遗传学、表观遗传学、感染、炎症和免疫 反应、环境因素和健康差异，以及干细胞和谱系可塑性；2)确定关键 3)吸引来自不同领域的顶尖科学家 4)促进基础研究、翻译研究和临床研究之间的互动 不同背景的科学家，促进跨学科的交流和合作；5)培养 妇女、少数群体、残疾人和早期职业调查人员的积极参与，为他们提供 介绍和讨论尖端科学并加强其与该领域的融合的机会；以及6) 传播和促进泌尿系统疾病的新发现。预计至少有250人参加， 我们将招募各种各样的临床医生、内科科学家和基础研究人员参加，特别是 重点关注职业生涯早期的研究人员和在泌尿外科研究中通常代表性较低的群体。最后，一个 NCI和NIDDK已经制定了强有力的计划来宣传会议和支持，如果获得支持的话。